Financhill
Back

Madrigal Pharmaceuticals Vs. Matinas BioPharma Holdings Industry Stock Comparison

Sell
50

MDGL
Madrigal Pharmaceuticals

Last Price:
$308.99
Seasonality Move:
15.43%
Sell
22

MTNB
Matinas BioPharma Holdings

Last Price:
$0.54
Seasonality Move:
13.52%
Sell
50
Madrigal Pharmaceuticals (MDGL) is a Sell

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $308.71. The Score for MDGL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Matinas BioPharma Holdings (MTNB) is a Sell

Is Matinas BioPharma Holdings a Buy, Sell or Hold?

  • The current Matinas BioPharma Holdings [MTNB] share price is $0.55. The Score for MTNB is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • MTNB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $308.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

MTNB Stock Price Chart

What is Matinas BioPharma Holdings's stock price today?

  • The Matinas BioPharma Holdings share price today is $0.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing slight buying pressure.

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 51.24 Buy
Chaikin Money Flow: 424640 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (300.88 - 330.4) Sell
Bollinger Bands (100): (218.15 - 309.67) Buy

MTNB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 31.02 Sell
Chaikin Money Flow: -19914 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.56 - 0.62) Sell
Bollinger Bands (100): (0.8 - 5.42) Sell

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 303.23 Buy
20-day SMA: 316.92 Sell
50-day SMA: 288.91 Buy
200-day SMA: 257.2 Buy
8-day EMA: 304.61 Buy
20-day EMA: 308.52 Buy
50-day EMA: 294.35 Buy
200-day EMA: 259.01 Buy

MTNB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Sell
20-day SMA: 0.59 Sell
50-day SMA: 1.38 Sell
200-day SMA: 6.37 Sell
8-day EMA: 0.57 Sell
20-day EMA: 0.66 Sell
50-day EMA: 1.42 Sell
200-day EMA: 5.65 Sell

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $4.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.12 per share, and an increase next year of $10.27 per share.

Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $1.06 per share.

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Matinas BioPharma Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):